Atlas Trials

Bortezomib and Rituximab in Treating Patients With Mantle Cell Lymphoma Who Have Previously Undergone Stem Cell Transplantation

Clinical trial NCT01267812 · COMPLETED

Trial details

NCT number
NCT01267812
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Contiguous Stage II Mantle Cell LymphomaNoncontiguous Stage II Mantle Cell LymphomaRecurrent Mantle Cell LymphomaStage I Mantle Cell LymphomaStage III Mantle Cell LymphomaStage IV Mantle Cell Lymphoma
Start date
2011-10-03
Primary completion
2020-11-02
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.